There is a lot of evidence that the blood plasma of patients with atherosclerosis is enriched in activation molecules, including chemokines which can drive CTL migration, e.g., CCL5, CCL4, CCL3, CX3CL1 (28, 29). Here, CX3CL1 is linked to atherosclerosis.